Immunomodulatory cartilage tissue engineering: synergistic inflammation suppression and cartilage regeneration for osteoarthritis treatment
Life Sciences · 2026
DOI: 10.1016/j.lfs.2025.124123 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life Sciences, 2026. Verfasst von Wenqi Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Shenzhen Campus, Sun Yat-Sen University, Shenzhen, 518107, China. Hauptthemen laut MEDLINE: Tissue Engineering, Osteoarthritis, Regeneration, Inflammation. Die Arbeit nennt 116 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Osteoarthritis (OA) is a prevalent degenerative joint disease characterized by progressive cartilage degradation and chronic inflammatory responses. Given the limited regenerative capacity of cartilage and the complexity of the inflammatory microenvironment, the treatment of OA presents significant clinical challenges. This review highlights the pivotal role of immune regulation in OA treatment and provides a comprehensive overview of the specific mechanisms and therapeutic applications of immunomodulatory cartilage tissue engineering mediated by biomaterials, bioactive additives, and cell intervention. A comparative analysis of these three approaches is conducted, clarifying their respective clinical relevance and feasibility. Furthermore, the review discusses the standardized assessment methods for immune regulation and tissue regeneration, and emphasizes the importance of establishing a unified evaluation framework for clinical translation. Finally, current challenges in immunomodulatory tissue engineering strategies for OA treatment are identified, and future directions for the development of personalized medicine are outlined in light of advancements in multi-omics technologies, generative artificial intelligence, and intelligent medical devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Shenzhen Campus, Sun Yat-Sen University, Shenzhen, 518107, China.
- School of Biomedical Engineering, Shenzhen Campus, Sun Yat-Sen University, Shenzhen, 518107, China; Shenzhen Institute for Drug Control, Shenzhen Testing Center of Medical Devices, Shenzhen, 518057, China.
- School of Biomedical Engineering, Shenzhen Campus, Sun Yat-Sen University, Shenzhen, 518107, China. Electronic address: zhchao9@mail.sysu.edu.cn.
- School of Biomedical Engineering, Shenzhen Campus, Sun Yat-Sen University, Shenzhen, 518107, China. Electronic address: xiaolin23@mail.sysu.edu.cn.
Förderung
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, W., Yang, Q., Huang, Y., Zhang, C., & Xiao, L. (2026). Immunomodulatory cartilage tissue engineering: synergistic inflammation suppression and cartilage regeneration for osteoarthritis treatment. Life Sciences. https://doi.org/10.1016/j.lfs.2025.124123
Vancouver
Zhang W, Yang Q, Huang Y, Zhang C, Xiao L. Immunomodulatory cartilage tissue engineering: synergistic inflammation suppression and cartilage regeneration for osteoarthritis treatment. Life Sciences. 2026. doi:10.1016/j.lfs.2025.124123
BibTeX
@article{Zhang2026,
author = {Zhang, Wenqi and Yang, Qianwen and Huang, Yuejun and Zhang, Chao and Xiao, Lin},
title = {Immunomodulatory cartilage tissue engineering: synergistic inflammation suppression and cartilage regeneration for osteoarthritis treatment},
journal = {Life Sciences},
year = {2026},
doi = {10.1016/j.lfs.2025.124123}
}
EUVIMED